0B68 Christopher, Theodore Arthur - Thomas Jefferson University - Thomas Jefferson University
tac104

Theodore A. Christopher, MD, FACEP

Contact Dr. Christopher

1020 Sansom Street
Thompson Building, Suite 239
Philadelphia, PA 19107

(215) 955-5105
(215) 503-5686 fax

Most Recent Peer-reviewed Publications

  1. C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform
  2. The development of the emergency medicine milestones
  3. Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion
  4. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway
  5. Expectations of an emergency medicine clerkship director
  6. Triage during the week of the Sichuan earthquake: A review of utilized patient triage, care, and disposition procedures
  7. Emergency medicine in the medical school curriculum.
  8. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance
  9. 111C The future of emergency medicine
  10. The future of emergency medicine
  11. Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actions
  12. Methylglyoxal increases cardiomyocyte ischemia-reperfusion injury via glycative inhibition of thioredoxin activity
  13. The future of emergency medicine
  14. The future of emergency medicine
  15. The dragon strikes: Lessons from the wenchuan earthquake
  16. Emergency medicine and political influence
  17. Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action
  18. Endothelial dysfunction in adiponectin deficiency and its mechanisms involved
  19. AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/ antinitrative protection of adiponectin
  20. Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation - A novel mechanism for the cardioprotective effects of PPAR agonists
0